Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 14 | $8,778,937 |
| Sells | 155 | $129,454,187 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Mar 2025 21:51 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 13 Mar 2025 | Sale | 1,078 | 89.4437 | 96,420 | D |
| 17 Mar 2025 21:51 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 17 Mar 2025 | Sale | 10,559 | 96.7086 | 1,021,146 | D |
| 17 Mar 2025 21:50 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 13 Mar 2025 | Sale | 402 | 90.0542 | 36,202 | D |
| 17 Mar 2025 21:50 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 17 Mar 2025 | Sale | 3,749 | 96.7098 | 362,565 | D |
| 11 Mar 2025 17:42 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 10 Mar 2025 | Sale | 922 | 94.7226 | 87,334 | D |
| 11 Mar 2025 17:40 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 10 Mar 2025 | Sale | 2,731 | 94.7254 | 258,695 | D |
| 04 Mar 2025 16:36 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 03 Mar 2025 | Sale | 261 | 103.94 | 27,128 | D |
| 31 Jan 2025 17:47 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Jan 2025 | Sale | 275 | 78.4804 | 21,582 | D |
| 31 Jan 2025 17:46 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Jan 2025 | Sale | 1,657 | 78.4828 | 130,046 | D |
| 10 Jan 2025 17:54 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 07 Jan 2025 | Sale | 24,073 | 93.3194 | 2,246,478 | D |
| 10 Jan 2025 17:54 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 07 Jan 2025 | Sale | 7,078 | 94.2791 | 667,307 | D |
| 10 Jan 2025 17:54 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 07 Jan 2025 | Sale | 3,455 | 95.6211 | 330,371 | D |
| 10 Jan 2025 17:54 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 07 Jan 2025 | Sale | 900 | 96.52 | 86,868 | D |
| 10 Jan 2025 17:53 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 07 Jan 2025 | Sale | 23,800 | 93.3379 | 2,221,442 | D |
| 10 Jan 2025 17:53 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 07 Jan 2025 | Sale | 8,439 | 94.3282 | 796,036 | D |
| 10 Jan 2025 17:53 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 07 Jan 2025 | Sale | 9,176 | 95.4972 | 876,282 | D |
| 10 Jan 2025 17:53 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 07 Jan 2025 | Sale | 10,005 | 96.3877 | 964,359 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 2,654 | 75.4735 | 200,307 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 2,051 | 76.5363 | 156,976 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 3,417 | 77.8811 | 266,120 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 4,078 | 78.576 | 320,433 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 4,242 | 79.6772 | 337,991 | D |
| 06 Jan 2025 18:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 02 Jan 2025 | Sale | 1,564 | 80.4734 | 125,860 | D |
| 06 Jan 2025 18:04 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 02 Jan 2025 | Sale | 319 | 75.0757 | 23,949 | D |
| 06 Jan 2025 18:04 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 02 Jan 2025 | Sale | 774 | 76.0004 | 58,824 | D |
| 06 Jan 2025 18:04 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 02 Jan 2025 | Sale | 337 | 77.0427 | 25,963 | D |
| 18 Dec 2024 18:22 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 Dec 2024 | Sale | 10,501 | 76.7541 | 805,995 | D |
| 18 Dec 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 16 Dec 2024 | Sale | 3,728 | 76.7541 | 286,139 | D |
| 11 Dec 2024 19:19 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 09 Dec 2024 | Sale | 3,661 | 76.3719 | 279,598 | D |
| 11 Dec 2024 19:18 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 09 Dec 2024 | Sale | 1,137 | 76.3728 | 86,836 | D |
| 03 Dec 2024 19:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 02 Dec 2024 | Sale | 263 | 78.3912 | 20,617 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 200 | 69.575 | 13,915 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 430 | 70.8447 | 30,463 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 969 | 71.8569 | 69,629 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 1,057 | 73.0005 | 77,162 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 5,524 | 73.7886 | 407,608 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 21 Nov 2024 | Sale | 3,839 | 74.9651 | 287,791 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 22 Nov 2024 | Sale | 5,162 | 75.3443 | 388,927 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 22 Nov 2024 | Sale | 2,711 | 76.4106 | 207,149 | D |
| 25 Nov 2024 18:21 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 22 Nov 2024 | Sale | 2,108 | 77.403 | 163,166 | D |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 19 Nov 2024 | Sale | 5,952 | 70.8642 | 421,784 | I |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 19 Nov 2024 | Sale | 24,784 | 71.3533 | 1,768,420 | I |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 19 Nov 2024 | Sale | 774 | 72.2565 | 55,927 | I |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 20 Nov 2024 | Sale | 9,361 | 68.3555 | 639,876 | I |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 20 Nov 2024 | Sale | 1,857 | 69.8379 | 129,689 | I |
| 21 Nov 2024 20:21 | WGS | GeneDx Holdings Corp | RYAN JASON | Director | 20 Nov 2024 | Sale | 4,272 | 70.502 | 301,185 | I |
| 19 Nov 2024 20:00 | WGS | GeneDx Holdings Corp | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 10% | 15 Nov 2024 | Sale | 20,359 | 69.7806 | 1,420,663 | D |
| 19 Nov 2024 20:00 | WGS | GeneDx Holdings Corp | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 10% | 18 Nov 2024 | Sale | 126,782 | 70.7755 | 8,973,059 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 5,497 | 68.6531 | 377,386 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 4,800 | 69.6748 | 334,439 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 7,240 | 70.7161 | 511,985 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 1,958 | 71.4897 | 139,977 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 2,043 | 72.9538 | 149,045 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 1,510 | 73.7099 | 111,302 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 15 Nov 2024 | Sale | 60 | 74.3389 | 4,460 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 800 | 66.6038 | 53,283 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 459 | 67.9364 | 31,183 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 3,151 | 68.9779 | 217,349 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 6,186 | 70.1507 | 433,952 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 8,580 | 70.9112 | 608,418 | D |
| 19 Nov 2024 19:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Nov 2024 | Sale | 3,131 | 71.8318 | 224,905 | D |
| 04 Nov 2024 17:01 | WGS | GeneDx Holdings Corp | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 10% | 31 Oct 2024 | Sale | 865,800 | 75 | 64,935,000 | D |
| 31 Oct 2024 17:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Oct 2024 | Sale | 274 | 66.6 | 18,248 | D |
| 31 Oct 2024 17:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Oct 2024 | Sale | 2,154 | 66.6 | 143,456 | D |
| 18 Sep 2024 16:28 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 Sep 2024 | Sale | 10,501 | 37.59 | 394,733 | D |
| 18 Sep 2024 16:26 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 16 Sep 2024 | Sale | 2,635 | 37.59 | 99,050 | D |
| 11 Sep 2024 20:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 09 Sep 2024 | Sale | 895 | 33.33 | 29,830 | D |
| 11 Sep 2024 20:10 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 09 Sep 2024 | Sale | 3,639 | 33.33 | 121,288 | D |
| 04 Sep 2024 20:10 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 03 Sep 2024 | Sale | 262 | 31.7096 | 8,308 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 19 Aug 2024 | Sale | 50,000 | 34.4904 | 1,724,520 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 16 Aug 2024 | Sale | 50,000 | 34.297 | 1,714,850 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 15 Aug 2024 | Sale | 39,824 | 33.0832 | 1,317,505 | D |
| 14 Aug 2024 16:50 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 12 Aug 2024 | Sale | 59,787 | 33.9507 | 2,029,811 | D |
| 14 Aug 2024 16:50 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 13 Aug 2024 | Sale | 24,987 | 34.7582 | 868,503 | D |
| 08 Aug 2024 17:39 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 08 Aug 2024 | Sale | 100,000 | 31.8238 | 3,182,380 | D |
| 08 Aug 2024 17:39 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 06 Aug 2024 | Sale | 12,994 | 29.3541 | 381,427 | D |
| 02 Aug 2024 16:21 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 31 Jul 2024 | Sale | 88,839 | 33.5027 | 2,976,346 | D |
| 31 Jul 2024 17:03 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 29 Jul 2024 | Sale | 50,000 | 33.8578 | 1,692,890 | D |
| 31 Jul 2024 16:40 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Jul 2024 | Sale | 2,154 | 33.54 | 72,245 | D |
| 31 Jul 2024 16:39 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 274 | 33.54 | 9,190 | D |
| 26 Jul 2024 19:49 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 26 Jul 2024 | Sale | 60,000 | 33.8543 | 2,031,258 | D |
| 26 Jul 2024 19:49 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 24 Jul 2024 | Sale | 75,000 | 33.7214 | 2,529,105 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 23 Jul 2024 | Sale | 75,000 | 33.4566 | 2,509,245 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 22 Jul 2024 | Sale | 50,000 | 32.6088 | 1,630,440 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 19 Jul 2024 | Sale | 25,000 | 32.29 | 807,250 | D |
| 19 Jul 2024 18:46 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 17 Jul 2024 | Sale | 25,000 | 32.9275 | 823,188 | D |
| 09 Jul 2024 16:07 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 05 Jul 2024 | Sale | 36,118 | 28.2412 | 1,020,016 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 03 Jul 2024 | Sale | 14,082 | 28.2269 | 397,491 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 02 Jul 2024 | Sale | 25,000 | 29.1238 | 728,095 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 01 Jul 2024 | Sale | 50,000 | 26.634 | 1,331,700 | D |
| 18 Jun 2024 17:18 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 17 Jun 2024 | Sale | 2,646 | 28.31 | 74,908 | D |
| 18 Jun 2024 17:17 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 17 Jun 2024 | Sale | 7,683 | 28.31 | 217,506 | D |
| 11 Jun 2024 16:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 10 Jun 2024 | Sale | 895 | 24.92 | 22,303 | D |
| 11 Jun 2024 16:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 10 Jun 2024 | Sale | 2,652 | 24.92 | 66,088 | D |
| 05 Jun 2024 20:45 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 04 Jun 2024 | Purchase | 30,000 | 22.5159 | 675,477 | D |
| 05 Jun 2024 20:45 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 03 Jun 2024 | Purchase | 100,000 | 20.8164 | 2,081,640 | D |
| 04 Jun 2024 16:20 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 03 Jun 2024 | Sale | 262 | 20.55 | 5,384 | D |
| 31 May 2024 17:37 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 29 May 2024 | Purchase | 40,000 | 21.0651 | 842,604 | D |
| 28 May 2024 20:40 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 28 May 2024 | Purchase | 18,304 | 20.6057 | 377,167 | D |
| 28 May 2024 20:40 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 24 May 2024 | Purchase | 144,196 | 20.1178 | 2,900,906 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)